| |
|
Leadership - Board of Directors
- Christopher Mirabelli, Ph.D., Chairman
Managing Director, HealthCare Ventures
- Stephen Knight, M.D.
Managing Partner, Fidelity Biosciences
- Lauren Silverman, Ph.D.
Managing Director, Novartis Option Fund
- Christopher T. Walsh, Ph.D.
Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology,
Harvard Medical School
- Alan Walts, Ph.D.
Managing Director, Genzyme Ventures
|
|
